NEW YORK, April 2, 2019 /PRNewswire/ --
Amyris, Inc. (AMRS)
Lifshitz & Miller announces investigation into possible securities laws violations in
connection with Amyris' announcement that it was unable to file its annual report for fiscal year ended December 31, 2018 on time.
If you are an Amyris investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at
info@jlclasslaw.com.
iRhythm Technologies, Inc. (IRTC)
Lifshitz & Miller announces investigation into possible securities laws violation in
connection with allegations concerning the sustainability of third-party reimbursements attributable to sales of Zio XT Extended
Holter patch device.
If you are an IRTC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at
info@jlclasslaw.com.
Orion Group Holdings, Inc. (ORN)
Lifshitz & Miller announces investigation into possible securities laws violations in
connection with ORN's announcement that it would not timely file its annual report with the SEC and "expects that a
significant change in results of operations from the corresponding period for the last fiscal year will be reflected in its
financial statements."
If you are an ORN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz,
Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Osmotica Pharmaceuticals (OSMT)
Lifshitz & Miller announces investigation into possible securities laws violation in
connection with Osmotica's announcement that its preliminary results for a second Phase 3 clinical trial of Arbaclofen
extended-release tablets failed to beat placebo as measured by the Clinical Global Impression of Change.
If you are an Osmotica investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz,
Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Quantenna Communications, Inc. (QTNA)
Lifshitz & Miller announces investigation into possible breach of fiduciary duties in
connection with the proposed sale of QTNA to ON Semiconductor Corporation for $24.50 per share.
If you are a Quantenna Communications investor, and would like additional information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz,
Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
WABCO Holdings, Inc. (WBC)
Lifshitz & Miller announces investigation into possible securities laws violation in
connection with the proposed merger of WBC with ZF Friedrichshafen AG for $136.50 per share.
If you are a WBC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Zafgen, Inc. (ZFGN)
Lifshitz & Miller announces investigation into possible securities laws violation in
connection with Zafgen's announcement that it had decided to suspend plans to file an investigational new drug application for
ZGN-1256 based on a finding in rodent toxicology studies.
If you are a Zafgen investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2019 Lifshitz & Miller LLP. The law firm responsible for
this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New
York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any
future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-amyris-inc-irhythm-technologies-inc-orion-group-holdings-inc-osmotica-pharmaceuticals-plc-quantenna-communications-inc-wabco-holdings-inc-and-zafgen-inc-300823364.html
SOURCE Lifshitz & Miller Law Firm